News
Objective Tofacitinib is an oral Janus kinase for the treatment of rheumatoid arthritis (RA). This post hoc analysis assessed whether baseline body mass index (BMI) impacts tofacitinib efficacy in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback